Bruce C. Cozadd
2017
In 2017, Bruce C. Cozadd earned a total compensation of $10.3M as Chairman and CEO at Jazz Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $961,800 |
|---|---|
| Option Awards | $3,669,875 |
| Salary | $950,385 |
| Stock Awards | $4,711,828 |
| Other | $10,722 |
| Total | $10,304,610 |
Cozadd received $4.7M in stock awards, accounting for 46% of the total pay in 2017.
Cozadd also received $961.8K in non-equity incentive plan, $3.7M in option awards, $950.4K in salary and $10.7K in other compensation.
Rankings
In 2017, Bruce C. Cozadd's compensation ranked 609th out of 14,666 executives tracked by ExecPay. In other words, Cozadd earned more than 95.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 609 out of 14,666 | 96th |
Division Manufacturing | 201 out of 5,770 | 97th |
Major group Chemicals And Allied Products | 47 out of 2,074 | 98th |
Industry group Drugs | 33 out of 1,730 | 98th |
Industry Pharmaceutical Preparations | 29 out of 1,329 | 98th |
Source: SEC filing on June 15, 2018.
Cozadd's colleagues
We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2017.
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2017
Michael Miller
Jazz Pharmaceuticals
Executive Vice President U.S Commercial
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019